Taysha Gene Therapies, Inc. TSHA Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s software and technology licenses, net?
- Taysha Gene Therapies, Inc. (TSHA) reported software and technology licenses, net of $181K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s software and technology licenses, net changed year-over-year?
- Taysha Gene Therapies, Inc.'s software and technology licenses, net decreased by 3.7% year-over-year, from $188K to $181K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s software and technology licenses, net?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s software and technology licenses, net has grown at a -36.2% compound annual growth rate (CAGR), from $1.11M to $183K.